Change in the prevalence of discontinuationa of statin therapy in the patient subgroups during the 5-year exposure period.

Repeated measures log-binomial regression analyses adjusted for age at retirement.a No purchases during a calendar year.bThe prevalence ratios of discontinuation are derived from contrasting the prevalence in the last year of follow-up to the prevalence in the first yearc Secondary prevention: previous in- or outpatient hospital visits due to coronary heart disease or cerebrovascular diseases in any year before retirement.Change in the prevalence of discontinuationa of statin therapy in the patient subgroups during the 5-year exposure period.